Related Experiment Videos
Drug Trials Snapshots and Sexless Drug Labels
G Elliott Cook1, Erin E Wilhelm2
1Provider Resources, Inc, Erie, Pennsylvania.
JAMA Internal Medicine
|December 6, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Reasons for Premature Conclusion of Late Phase Clinical Trials: An Analysis of ClinicalTrials.gov Registered Phase III Trials.
Therapeutic innovation & regulatory science·2020
A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data.
Journal of diabetes and its complications·2017
Data sharing for public health research: A qualitative study of industry and academia.
Communication & medicine·2015
Advancing a Vision for Regulatory Science Training.
Clinical and translational science·2015
Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes.
JAMA internal medicine·2026
Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial.
JAMA internal medicine·2026
Epidemiologic Study of Transfusion-Related Alpha-Gal Syndrome.
JAMA internal medicine·2026
Serologic Immunity to Hepatitis A and B in US Adults and High-Risk Populations.
JAMA internal medicine·2026
Management of Shoulder Pain in Primary Care: A Review.
JAMA internal medicine·2026
Cendakimab for Eosinophilic Gastritis and Duodenitis in Japanese Adults and Adolescents: Results From a Phase 3 Randomized Controlled Trial.
The American journal of gastroenterology·2026
Buprenorphine Dispensed by Pharmacies and Administered in Emergency Departments in Urban and Rural Areas - United States, 2019-2025.
MMWR. Morbidity and mortality weekly report·2026
Rheumatoid arthritis guidelines require More Specific dietary recommendations: An overlooked opportunity.
Clinical nutrition ESPEN·2026
Assessment of the impact of valproic acid co-administration on clozapine plasma concentrations in Tunisian patients.
Drug metabolism and personalized therapy·2026
Benefit-Risk of Voxelotor, Crizanlizumab, and L-Glutamine in Sickle Cell Disease: A Systematic Review.
The American journal of the medical sciences·2026